Orlistat-Mepha 120, Kapseln

7680626630022 CH-62663 Kapseln
Orlistat-Mepha 120, Kapseln
Orlistat-Mepha 120, Kapseln
1 / 2
google

Article details

Package size
84
Selling units
84
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/08/2023
Patient information leaflet
Français
07/08/2023
Patient information leaflet
Italien
07/08/2023
Summary of Product Characteristics
Allemand
07/08/2023
Summary of Product Characteristics
Français
07/08/2023
Summary of Product Characteristics
Italien
07/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
1.926 MG Substance HBESI

Reimbursement information

Public price
CHF 66.80
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/04/2013

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
62663
Drug name
Orlistat-Mepha 120, Kapseln
Galenic form
KAHA
ATC Code
A08AB01
Authorization status
Z
Dispensing category
B
First authorization
20/06/2012
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Antiadipositum, peripher wirksames Präparat zur Gewichtsreduktion

Package details

Description (FR)
ORLISTAT Mepha caps 120 mg 84 pce
Description (DE)
ORLISTAT Mepha Kaps 120 mg 84 Stk
Market launch
20/06/2012
Narcotic (BTM)
No

Original drug

Xenical, Kapseln
GTIN: 7680542820361
CHF 53.30
View original

Other package sizes (1)

ORLISTAT Mepha caps 120 mg 42 pce
42 KAP
GTIN: 7680626630015
View